Novel immune system-based gene therapy induces strong responses in metastatic melanoma, sarcoma

Researchers have found that a novel form of personalized therapy that genetically engineers a patient's own anti-tumor immune cells to fight tumors could treat metastatic melanoma and metastatic synovial cell sarcoma, representing a potentially new therapeutic approach against these and other cancers.

Read the whole article on Physorg

More from Physorg